Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-19
2011-10-04
Saeed, Kamal (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S222000, C548S255000, C544S284000, C544S356000, C544S265000, C544S238000, C546S115000, C546S271700, C514S249000, C514S252060, C514S255050, C514S263200, C514S275000, C514S338000, C514S367000, C514S375000, C514S395000
Reexamination Certificate
active
08030495
ABSTRACT:
The present invention is directed to cyclopropyl proline bis-amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
REFERENCES:
patent: 5229396 (1993-07-01), Brighty
patent: 6927200 (2005-08-01), Bodet et al.
patent: 7582659 (2009-09-01), Fukuda
patent: 2004/0122017 (2004-06-01), Chader et al.
patent: 2010/0016401 (2010-01-01), Aissaoui et al.
patent: 2010/0204285 (2010-08-01), Aissaoui et al.
patent: WO 2004080463 (2004-09-01), None
patent: WO 2008/038251 (2008-04-01), None
patent: WO 2008/081399 (2008-07-01), None
patent: WO 2009/004584 (2009-01-01), None
patent: WO 2009/016560 (2009-02-01), None
patent: WO 2009/016564 (2009-02-01), None
International Preliminary Report on Patentability for WO 2008/150364, (Nov. 24, 2009).
Coleman, et al., Expert Opin. Ther. Patents (2010), 20(3), 307-324.
Coleman Paul J.
Mercer Swati P.
Roecker Anthony J.
Devlin Gerard M.
Grazier Nyeemah A
Saeed Kamal
Thies J. Eric
LandOfFree
Cyclopropyl pyrrolidine orexin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclopropyl pyrrolidine orexin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopropyl pyrrolidine orexin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4280650